Trial Information

Summary: A Study of Xeloda (Capecitabine) in Patients With Advanced or Metastatic Gastric Cancer

Status: No longer recruiting

Protocol Number: ML17032

Sponsor: Roche Products Pty Ltd

Company Division: Pharmaceutical

Official Scientific Title: A randomized, open-label study of the effect of first-line chemotherapy with Xeloda plus cisplatin versus 5-fluorouracil plus cisplatin on time to disease progression in patients with advanced or metastatic gastric cancer

Brief Summary: This study will evaluate the efficacy and safety of oral Xeloda versus 5-fluorouracil, in combination with intravenous cisplatin, in patients with advanced and/or metastatic gastric cancer. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals. Target sample size is 300.

Study Phase: III

Study Design / Study Details:

  • Purpose: Treatment
  • Allocation: Randomized
  • Masking: Open Label
  • Control: Active
  • Assignment: Parallel
  • Endpoints: Safety/Efficacy

Study Type:

Interventional

Condition: Gastric Cancer

Intervention Type: Drug

Intervention Name: capecitabine[Xeloda]

Primary Outcome: 1. Efficacy: Non-inferiority, time to progression of disease, or death.

Key Secondary Outcomes: 1. Efficacy: Overall response rate, survival time, duration of response, and time to response Safety: Adverse events and laboratory tests

Inclusion Criteria:

  • adult patients, 18-75 years of age;
  • advanced and/or metastatic gastric cancer;
  • >=1 measurable lesion.

Exclusion Criteria:

  • uncontrolled infection;
  • evidence of central nervous system metastases;
  • history of another malignancy within the last 5 years except cured basal cell cancer of skin and cured in-situ cancer of uterine cervix;
  • radiation therapy or major surgery within 4 weeks of treatment start;
  • previous chemotherapy.

Gender: Males or Females

Age Limits: Min: 18 Years Max: 75 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: April, 2003

Trial Registration Date: 08/31/2005

Date Last Updated: 07/15/2008

Link To Trial Results

Contact:

Research Site:
Located In:
Shanghai, China, 200001
Telephone: 973-235-5000 or 800-526-6367

  

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 21, 2008 at 2:15:03 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA